Cargando…
Engineering a novel IgG-like bispecific antibody against enterovirus A71
Frequent outbreaks of enterovirus A71 (EVA71) occur in the Asia-Pacific area, and these are closely associated with severe neurological symptoms in young children. No effective antiviral therapy is currently available for the treatment of EVA71 infection. The development of monoclonal antibodies (mA...
Autores principales: | Wang, Hsiang-Ching, Hung, Hui-Chen, Huang, Peng-Nien, Kung, Yu-An, Tseng, Sung-Nien, Wang, Yun-Ming, Shih, Shin-Ru, Tsu-An Hsu, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164134/ https://www.ncbi.nlm.nih.gov/pubmed/34095549 http://dx.doi.org/10.1016/j.bbrep.2020.100860 |
Ejemplares similares
-
Engineering IgG-Like Bispecific Antibodies—An Overview
por: Krah, Simon, et al.
Publicado: (2018) -
Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019) -
Human IgG Fc promotes expression, secretion and immunogenicity of enterovirus 71 VP1 protein
por: Xu, Juan, et al.
Publicado: (2016) -
Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection
por: Cao, Rui-Yuan, et al.
Publicado: (2013) -
Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity
por: Jia, Qiang, et al.
Publicado: (2017)